Piramal divests its DRG Business for $950 million
PEL had initially invested US$650 Million in 2012 to acquire DRG out of which $260 Mn was infused as equity
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Piramal
Piramal’s Pharma business grows over 10 per cent in FY19
Growth is attributed to revenues derived from niche businesses of complex generics and Contract Development and Manufacturing…